Pharma
Pfizer’s RSV Vaccine Abrysvo Expands Approval to High-Risk Adults Under 60
Pfizer’s Respiratory Syncytial Virus (RSV) vaccine, Abrysvo, recently received FDA approval for use in adults aged 18 to 59 who are at increased risk for
Discover healthcare innovations emerging from global markets. Follow the medical advancements, research breakthroughs, and technologies that are addressing local challenges and making a global impact in healthcare delivery.
Pfizer’s Respiratory Syncytial Virus (RSV) vaccine, Abrysvo, recently received FDA approval for use in adults aged 18 to 59 who are at increased risk for
In a significant breakthrough, the FDA has approved two new drugs for the treatment of Niemann-Pick Disease Type C (NPC), a rare and debilitating genetic
In an exciting new development, Booster Therapeutics has entered the biotech space with a $15 million seed funding round. The company, which officially launched on
Cambridge-based biotech company Shift Bioscience has raised $16 million in seed funding to drive forward its cellular reprogramming research aimed at combating age-related diseases. The
Biotechnology is advancing rapidly, driving innovation across healthcare, agriculture, food, and manufacturing. At the forefront of these advancements are gene editing technologies like CRISPR/Cas9, which
The medical technology (medtech) industry is one of the most critical sectors in healthcare, driving innovation in diagnostics, treatment, and patient care. The following are
Medical device innovation is no longer limited to traditional markets like the United States and Europe. Emerging markets across Asia, Africa, and Latin America are
3D printing is revolutionizing the field of medicine, especially in surgical procedures and patient recovery. What once seemed futuristic is now a rapidly growing reality,
The healthcare landscape in 2024 is poised for significant advancements as key medical devices and therapies await FDA approval. These anticipated approvals hold the potential